Detalhe da pesquisa
1.
A phase II clinical trial evaluating the safety and efficacy of durvalumab as first line therapy in advanced and metastatic non-small cell lung cancer patients with Eastern Cooperative Oncology Group performance status of 2.
EClinicalMedicine
; 66: 102317, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38192592
2.
Successful management of life-threatening hemorrhage in a patient with synchronous lupus anticoagulant and factor VIII inhibitor.
J Vasc Surg
; 36(4): 853-5, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12368750